Page 25 - Revista SPORL - Vol 47. Nº1
P. 25

devem também ser propostas, tendo em conta a expe-  22. Bales C, Kotapka M, Loevner LA, et al. Craniofacial resection of advanced juvenile
             riência da equipa cirúrgica do centro respectivo. Nos es-  nasopharyngeal angiofibroma. Arch Otolaryngol Head Neck Surg. 2002;128:1071,-
                                                                 1078.
             tadios precoces deve-se optar por vias que impliquem  23. Dare AO, Gibbons KI, Proulx GM, Fenstermaker RA. Resection followed by
             menos mutilação, nomeadamente a via endoscopica     radiosurgery for advanced juvenile nasopharyngeal angiofibroma, report of two cases.
                                                                 Neurosurgery. 2003:52:1207-1211,
             transnasal. Nos estadias mais avançados deve-se esco-  24. Pryor SO, Moore EJ, Kasperbauer. Endoscopic versus traditional approaches for excision
             lher as vias externas.                              of juvenile nasopharyngeal angiofibroma. Laryngoscope. 2005;115:1201-1207,
                Mesmo havendo uma provável relação com maior
             taxa de persistencia/ recidiva, deve-se realizar a emboli-
             zação pré-operatória evitando desta forma complicações
             intraoperatórias.

             AGRADECIMENTOS
             Agradecimentos à Dra Sara Baptista pelas sugestões
             muito pertinentes na execução deste artigo.





             REFERENCIAS                                                                                          ARTIGO DE REVISA.0
             1. Herva S, Portier F, Chapot R, et al. Fibroma nasofaringeo. Encyclopédie Médico-
              Chirurgicale 2007. 20-585-A-10.
             2, Antonelli AR, Cappello J, Di Lorenzo D, et al. Diagnosis, staging and treatment of
              juvenile nasopharyngeal anglofibroma. Laryngoscope. 1987;97:1319-1325.
             3. Fagan ii, Snyderman CH, Carrau RL, et al. Nasopharyngeal angtofibromas: selecting a
              surgical approach. Head Neck. 199719:391-399.
             4, El-Banhaway DA, El-Dien AES, Amer T. Endoscopc-assisted midfacial degloving approach
              for type III juvenile angiofibroma. Intl Pediatr Otorhinolaryngol. 2004;68:21-28.
             5, Gaffney R. Hui Y, Vojvodich S., Forte Vito. Extranasopharyngeal angiofibroma of the
              inferior turbinate, Int J Pediatr Otorhinolaryngol. 1997;40:177-180.
             6. Schick 8, Kind M, Draf W, et al. Extranasopharyngeal angiofibroma in a 15-month-old
              child. mi  Pediatr Otorhinolaryngo1.1997:42:135-140.
             7. Gatalica Z. lmmunohistochemical analysis of steroid hormone receptors in
              nasopharyngeal angiofibromas. Cancer Lett. 1998;127:89-93.
             8. Nagai MA, Butugan 0, Logullo A,et ai.. Expression of growth factors, proto-oncogenes,
              and p53 in nasopharyngeal angiofibromas. Laryngoscope, 1996:106:190-195,
             9. Zhang P, Weber R, Liang HH, et al. Growth factors and receptors in juvenile
              nasopharyngeal angiofibroma and nasal polyps. Arch Pathol Lab Med. 2003;127:1480-
              1484.
             10. Schick B, Brunner C, Praetorius M, et al. First evidence of genetic imbalances in
               angiofibromas. Laryngoscope. 2002,112:397-401.
             11 Jacobsson M, Petruson B, Ruth M, et al. Involution of juvenile nasopharyngeal
               angiofibroma with intracranial extension. Arch Otolaryngol Head Neck Surg.
               1989;115:238-239.
             12 Weprin LS, Sierners PT. Spontaneous regression of juvenile nasopharyngeal
               angiofibroma, Arch Otolaryngol Head Neck Surg. 1991;117:796-799.
             13 Kasper MK, Parsons IT, Mancuso AA, et al. Radiation therapy for Juvenile angiofibroma:
               evaluation by CT and MRI, analysis of tumor regression, and selection of patients. Int
               J Radiation Oncology Biol Phys. 1993;25:689-694.
             14 Radkowski D, McGill T, Healy GI, et al, Angbfilarorna, changes in staging and
               treatment. Arch Otolaryngol Head Neck, 1996;122:122-129.
             15 Tyagi I, Syal R, Goyal A. Recurrent and residual juvenile angiofibromas. I Laryngol
               Otol. 2007;121:460-7.
             16 Herman P, Lot G, Chapot R, et al. Long term follow up of juvenile nasopharyngeal
               angiofibromas: analysis of recurrence. Laryngoscope. 1999,109:140-147,
            17 El-Banhawy DA, Ragab A, El-Sharnoby MM. Surgical resection of type HI juvenile
              angiofibroma without preoperative embolization. Int I Pediatr Otorhinolaryngol,
               2006;70:1715-1723,
            18 Scholtz A, Appenroth E, Kammen-Jolly K, et al. Juvenile nasopharyngeal angiofibroma:
               management and therapy. Laryngoscope. 2001;111:681-687.
            19 Hardillo iA, Velden LV, Knegt PP Denker operation is an effective surgical approach
              in managing juvenile nasopharyngeal angiofibroma, Ann Otol Rhinol Laryngol.
              2004;113:946-950.
            20 Cansiz H, Güvenc G, Sekercioglu N. Surgical approaches to juvenile nasopharyngeal
              angiofibroma. I Craniofac Surg. 2006;34:3-8.
            21 Worrnald PT, Van Hasselt A. Endoscopic removal of juvenile angiofibromas. Otolaryngol
              Head Neck Surg. 2003;129:684-691.


                                                                                         VOL 47 N'l  MARÇO 2009 23
   20   21   22   23   24   25   26   27   28   29   30